The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals

Stat News

25 January 2023 - Congress just boosted the FDA’s authority over the post-market clinical trials that are a condition of speedy drug approvals, and industry lobbyists are anxious to know how the agency plans to wield that new power, which includes criminal prosecution.

The FDA's accelerated approval program is popular with patients who want treatments for life-threatening conditions as soon as possible.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder